Skip to content
Independent analysis of NHS open data
PharmaInsight

Certolizumab pegol

Musculoskeletal and Joint Diseases Drugs used in rheumatic diseases and gout BNF 1001030Y0
Data updated October 2024 Download CSV
1items

Dispensed in October 2024

0items

Rolling 12 months

£358

Net ingredient cost · October 2024

Figure 1. Certolizumab pegol: national items dispensed by month

0 0.5 1 Apr 2021 Jan 2022 Nov 2023 Mar 2024 Sep 2024 Oct 2024 1 Apr 2021: 1 Jan 2022: 1 Nov 2023: 1 Mar 2024: 1 Sep 2024: 1 Oct 2024: 1

Source: NHSBSA Prescription Cost Analysis, to October 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs used in rheumatic diseases and gout
  • Presentations 1 shown
  • Average cost / item £357.50
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, October 2024

The individual products dispensed under Certolizumab pegol this month.

Presentations of Certolizumab pegol, October 2024
Presentation BNF code Items Net ingredient cost
Cimzia 200mg/1ml solution for injection pre-filled syringes 1001030Y0BBAAAA 1 £358

Source: NHSBSA Prescription Cost Analysis · to October 2024 OGL v3.0

Where Certolizumab pegol is dispensed

The regions and dispensing practices with the highest Certolizumab pegol volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Certolizumab pegol is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Certolizumab pegol with

Other medicines in the same BNF section, by prescribing volume.